after 6 months' intervention, compared to wrf supplementation, brf supplementation greatly enhanced plasma total antioxidant capacity (tac) (p=0.003), significantly reduce plasma levels of soluble vascular cell adhesion molecule-1 (svcam-1) (p=0.03), soluble cd40 ligand (scd40l) (p=0.002) and high sensitive c-reactive protein (hs-crp) (p=0.002) in the test group.